Cover of Danaya Azure Podcast

Danaya Azure Podcast

Danaya Azure Podcast

By: Danaya Azure Podcast
Listen for free

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.
Summary
Danaya Azure Radio broadcasting every Thursday, partnered with Nexxlegacy is the global phenomena catered to the growth of music evolution of all genres. Birthed with Chi-Town grass roots, this programming targets a diverse soulful sound stream that centers from hip-hop, neo-soul-R&B, pop, rock and a lot more. The first of its kind to house a Nexxlegacy Honors soundtrack to honor the artist living on a weekly basis. With diverse interviews to International music mixes, album reviews and a New Music Track list this go-to station is for listeners of all ages.Danaya Azure Podcast Politics & Government
Episodes
  • Robert Ellin Interview
    26 Aug 2025

    Robert Ellin CEO of LVO Is My Guest On Danaya Azure Radio

    www.danayaazure.com

    On this episode of Danaya Azure Radio, I sit down with Robert Ellin, CEO of LiveOne, the global platform for live and on-demand entertainment. 🎶 We talk about innovation in music and media, the future of streaming, and how LiveOne is creating unique experiences for artists and fans worldwide. Don’t miss this powerful conversation with one of the leading voices in digital entertainment.

    Show more Show less
    6 min
  • Doug Gaylor CEO of Crexendo
    26 Aug 2025

    Doug Gaylor CEO of Crexendo is my guest on guest On Danaya Azure Radio

    www.danayaazure.com

    In this episode of Danaya Azure Radio, my guest is Doug Gaylor, CEO of Crexendo. 🎙️ We explore how Crexendo is transforming the future of cloud communications, empowering businesses with innovative technology solutions, and driving growth in the digital age. Tune in for valuable insights on leadership, innovation, and what it takes to stay ahead in a fast-changing industry.

    Show more Show less
    4 min
  • Leonard Mazur CEO Of Citius Pharmasuticals
    25 Aug 2025

    Leonard Mazur CEO Of Citius Pharmasuticals

    www.danayaazure.com

    https://citiuspharma.com/

    Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products. LYMPHIR™ (denileukin diftitox-cxdl), our targeted immune therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL) is now approved by the FDA. Commercialization efforts are underway to make this therapy available to patients.

    Our team’s extensive experience in the pharmaceutical industry allows us to identify compelling opportunities and develop assets that have unique commercial advantages and differentiated upside potential. By deploying capital thoughtfully, we believe our activities will provide patients and caregivers with improved treatment options and deliver long-term sustainable value to shareholders.

    Show more Show less
    5 min
adbl_web_anon_alc_button_suppression_t1
No reviews yet